Fort Washington Investment Advisors Inc Pfizer Inc Transaction History

Fort Washington Investment Advisors Inc

$16 Billion
Q3 2024

A detailed history of Fort Washington Investment Advisors Inc transactions in Pfizer Inc stock. As of the latest transaction made, Fort Washington Investment Advisors Inc holds 1,606,826 shares of PFE stock, worth $41.5 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

1,606,826

Previous 1,599,879 0.43%

Holding current value

$41.5 Million

Previous $44.8 Million 3.88%

% of portfolio

0.29%

Previous 0.3%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$27.7 - $31.39 $192,431 - $218,066	6,947 Added 0.43%	1,606,826 $46.5 Million
Q2 2024 Jul 30, 2024	SELL	$25.26 - $29.6 $2.96 Million - $3.47 Million	-117,347 Reduced 6.83%	1,599,879 $44.8 Million
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $130,589 - $149,958	5,044 Added 0.29%	1,717,226 $47.7 Million
Q4 2023 Jan 17, 2024	BUY	$26.13 - $33.94 $571,123 - $741,826	21,857 Added 1.29%	1,712,182 $49.3 Million
Q3 2023 Nov 07, 2023	BUY	$32.09 - $37.51 $20.9 Million - $24.4 Million	651,554 Added 62.72%	1,690,325 $56.1 Million
Q2 2023 Jul 28, 2023	BUY	$36.12 - $41.79 $8.47 Million - $9.8 Million	234,392 Added 29.14%	1,038,771 $38.1 Million
Q1 2023 Apr 28, 2023	SELL	$39.39 - $51.28 $3.71 Million - $4.82 Million	-94,066 Reduced 10.47%	804,379 $32.8 Million
Q4 2022 Jan 30, 2023	BUY	$41.75 - $54.5 $133,934 - $174,836	3,208 Added 0.36%	898,445 $46 Million
Q2 2022 Aug 05, 2022	BUY	$46.53 - $55.17 $641,322 - $760,408	13,783 Added 1.56%	895,237 $46.9 Million
Q1 2022 May 03, 2022	SELL	$45.75 - $56.69 $6.09 Million - $7.55 Million	-133,094 Reduced 13.12%	881,454 $45.6 Million
Q4 2021 Feb 07, 2022	SELL	$41.32 - $61.25 $22.8 Million - $33.8 Million	-552,495 Reduced 35.26%	1,014,548 $59.9 Million
Q3 2021 Nov 09, 2021	BUY	$39.25 - $50.42 $47.5 Million - $61 Million	1,209,081 Added 337.77%	1,567,043 $67.4 Million
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $23,341 - $26,442	650 Added 0.18%	357,962 $14 Million
Q1 2021 May 05, 2021	BUY	$33.49 - $37.77 $193,471 - $218,197	5,777 Added 1.64%	357,312 $12.9 Million
Q4 2020 Feb 03, 2021	BUY	$33.47 - $42.56 $428,114 - $544,384	12,791 Added 3.78%	351,535 $12.9 Million
Q3 2020 Nov 10, 2020	BUY	$31.75 - $37.25 $241,585 - $283,435	7,609 Added 2.3%	338,744 $12.4 Million
Q1 2020 May 06, 2020	SELL	$27.03 - $38.62 $1.22 Million - $1.74 Million	-45,133 Reduced 11.99%	331,135 $10.8 Million
Q4 2019 Feb 03, 2020	BUY	$32.92 - $37.36 $3.05 Million - $3.46 Million	92,564 Added 32.63%	376,268 $14.7 Million
Q3 2019 Nov 08, 2019	BUY	$32.49 - $42.13 $3 Million - $3.88 Million	92,190 Added 48.14%	283,704 $10.2 Million
Q2 2019 Aug 12, 2019	BUY	$36.98 - $41.52 $11,278 - $12,663	305 Added 0.16%	191,514 $8.3 Million
Q1 2019 May 10, 2019	SELL	$37.5 - $41.2 $639,375 - $702,460	-17,050 Reduced 8.19%	191,209 $8.12 Million
Q4 2018 Feb 05, 2019	SELL	$38.47 - $43.86 $3.1 Million - $3.53 Million	-80,569 Reduced 27.9%	208,259 $9.09 Million
Q3 2018 Nov 07, 2018	SELL	$34.47 - $41.81 $29,127 - $35,329	-845 Reduced 0.29%	288,828 $12.7 Million
Q2 2018 Jul 27, 2018	BUY	$32.98 - $35.16 $18,369 - $19,584	557 Added 0.19%	289,673 $10.5 Million
Q1 2018 May 02, 2018	SELL	$31.91 - $37.02 $1.63 Million - $1.89 Million	-51,063 Reduced 15.01%	289,116 $10.3 Million
Q4 2017 Feb 12, 2018	SELL	$33.26 - $35.29 $72,739 - $77,179	-2,187 Reduced 0.64%	340,179 $12.3 Million
Q3 2017 Nov 13, 2017	SELL	$31.0 - $34.15 $399,435 - $440,022	-12,885 Reduced 3.63%	342,366 $12.2 Million
Q2 2017 Aug 10, 2017	BUY	N/A	355,251	355,251 $11.9 Million

Others Institutions Holding PFE

# of Institutions

3,259

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Washington Investment Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Fort Washington Investment Advisors Inc with notifications on news.

Account

Fort Washington Investment Advisors Inc Pfizer Inc Transaction History